| Literature DB >> 33919529 |
Wei-Yuan Yao1, Meng-Ge Han1, Giuseppe De Vito2, Hong Fang3, Qinghua Xia4, Yingyao Chen5, Xiaona Liu1, Yan Wei1,5, Russell L Rothman6, Wang-Hong Xu1,5.
Abstract
This secondary analysis was designed to evaluate the independent effect of physical activity (PA) on hemoglobin A1c (HbA1c) level in Chinese patients with type 2 diabetes mellitus (T2DM). A total of 799 T2DM patients from eight communities of Shanghai, China, were randomized into one control arm and three intervention arms receiving 1-year interventions of health literacy, exercise, or both. PA was measured using the International Physical Activity Questionnaire at baseline, 12 months, and 24 months and quantified as metabolic equivalents (Mets). A multiple level mixed regression model was applied to evaluate the associations between PA and HbA1c level. After adjusting for potential confounders including interaction of PA level with initial PA or HbA1c, a significant improved HbA1c was observed for the patients in the medium versus the lowest tertile groups of overall PA at 12 months (β: -3.47, 95%CI: -5.33, -1.60) and for those in the highest versus the lowest tertile group at 24 months (β: -0.50, 95%CI: -1.00, -0.01), resulting in a β (95%CI) of -3.49 (95%CI: -5.87, -1.11) during the whole two-year period of follow-up. The negative association was also observed when the subjects were classified according to their exercise levels using the World Health Organization (WHO) recommendation as a cut-off point. The beneficial effect of higher PA level was only observed among patients having a lower level of baseline HbA1c or PA or both (all p values for interaction <0.05). Our results provide evidence for the beneficial effect of PA and suggest that the exercise intervention should be addressed to the physically inactive patients to improve their PA level to a physiological threshold.Entities:
Keywords: glycemic control; physical activity; randomized control trial; type 2 diabetes
Year: 2021 PMID: 33919529 PMCID: PMC8073010 DOI: 10.3390/ijerph18084292
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram of the study. PA: Physical Activity; T1-T3: Group 1–3 by tertiles of PA; G1-G2: Group 1-2 by WHO (World Health Organization) recommended exercise level.
Physical activity (PA) levels during the study period among diabetes patients in four arms.
| Median (IQR) of PA (METs-h/w) | Intervention Groups | Control Arm | |||
|---|---|---|---|---|---|
| Health Literacy | Exercise | Comprehensive | |||
| At baseline | |||||
| Overall | 56.0 (30.0, 84.0) | 50.5 (33.5, 80.7) | 50.0 (28.0, 90.0) | 71.5 (53.0, 108.0) | <0.001 |
| Exercise | 0 (0, 14.0) | 4.0 (0, 20.0) | 0 (0, 20.0) | 7.5 (0, 28.0) | 0.01 |
| Commute | 18.7 (0, 30.2) | 16.0 (8.0, 28.0) | 12.0 (0, 28.0) | 28.0 (14.0, 29.0) | <0.001 |
| Housework | 21.0 (4.5, 42.0) | 21.0 (10.5, 42.0) | 21.0 (10.5, 42.0) | 42.0 (21.0, 52.5) | <0.001 |
| Sedentariness | 35.0 (28.0, 49.0) | 31.5 (21.0, 49.0) | 28.0 (14.1, 35.0) | 24.5 (14.0, 31.5) | <0.001 |
| At 12 months | |||||
| Overall | 41.8 (16.9, 66.1) * | 70.0 (41.5, 97.4) * | 55.0 (28.0, 81.0) | 73.7 (44.3, 108.3) | <0.001 |
| Exercise | 0 (0, 10.0) | 12.0 (0, 22.7) | 8.2 (0, 28.0) | 7.3 (0, 28.0) | <0.001 |
| Commute | 10.0 (0, 28.0) * | 23.3 (10.0, 38.5) * | 12.0 (0, 28.0) | 28.0 (6.3, 42.0) | <0.001 |
| Housework | 18.0 (5.0, 42.0) * | 30.8 (9.0, 42.0) | 21.0 (7.5, 42.0) * | 31.5 (10.5, 42.0) * | 0.001 |
| Sedentariness | 28.0 (21.0, 35.0) * | 28.0 (21.6, 35.0) * | 28.0 (21.0, 35.0) | 28.0 (21.0, 42.0) * | 0.94 |
| At 24 months | |||||
| Overall | 39.5 (17.8, 69.4) * | 57.0 (29.0, 91.0) + | 64.8 (30.8, 104.5) + | 70.0 (36.0, 110.0) | <0.001 |
| Exercise | 0 (0, 4.7) *+ | 4.0 (0, 20.0) + | 17.0 (0, 38.0) *,+ | 8.0 (0, 24.0) | <0.001 |
| Commute | 10.0 (0, 28.0) * | 18.7 (8.0, 42.0) * | 13.7 (0, 30.0) + | 14.0 (0, 30.7) | <0.001 |
| Housework | 21.0 (6.0, 42.0) + | 21.0 (9.0, 42.0) + | 21.0 (9.0, 42.0) * | 31.5 (10.5, 49.0) * | 0.03 |
| Sedentariness | 35.0 (21.0, 42.0) *+ | 31.5 (21.0, 45.5) + | 28.0 (21.0, 42.0) * | 28.0 (17.5, 35.0) * | <0.001 |
PA: Physical Activity; IQR: interquartile range; METs-h/w: metabolic equivalents (METs)-hours per week. a ANOVA tests (normal distributed) or Kruskal–Wallis tests (non-normal distributed) for group-comparisons; * p < 0.05 for differences in PA level between baseline and 12 months and between baseline and 24 months within each group using a mixed linear model; + p < 0.05 for difference in PA level between 12 and 24 months within each group using a mixed linear model.
β and 95%CI of hemoglobin A1c (HbA1c) during the following-up with baseline characteristics of the study participants.
| Baseline Characteristics | HbA1c Level (%, Median, IQR) | β Coefficients (SE) | |||
|---|---|---|---|---|---|
| At baseline | At 12-months | At 24-months | Unadjusted | Adjusted a | |
| Age (years) | |||||
| <65 | 8.1 (7.5, 9.0) | 8.0 (6.9, 9.1) | 7.9 (7.0, 9.1) | 0 (ref) | 0 (ref) |
| ≥65 | 8.1 (7.6, 9.2) | 8.0 (7.1, 9.1) | 7.9 (6.9, 9.1) | 0.05 (0.10) | 0.06 (0.14) |
| Sex (%) | |||||
| Men | 8.1 (7.6, 9.1) | 8.1 (7.1, 9.2) | 7.9 (7.0, 9.1) | 0 (ref) | 0 (ref) |
| Women | 8.1 (7.5, 9.1) | 8.0 (7.1, 9.1) | 7.8 (6.9, 9.1) | −0.11 (0.10) | −0.11 (0.09) |
| Educational level (%) | |||||
| Primary school or below | 8.1 (7.5, 8.9) | 8.1 (7.2, 9.3) | 8.1 (7.2, 9.7) | 0 (ref) | 0 (ref) |
| Junior high school | 8.2 (7.6, 9.3) | 8.1 (7.1, 9.2) | 7.9 (7.0, 9.1) | −0.13 (0.13) | −0.23 (0.13) |
| Senior high school | 8.1 (7.6, 8.9) | 8.0 (7.1, 8.8) | 7.9 (7.0, 8.9) | −0.20 (0.14) | −0.25 (0.13) |
| College and above | 7.9 (7.4, 8.7) | 7.6 (6.7, 9.1) | 7.5 (6.7, 8.6) | −0.31 (0.17) | −0.29 (0.16) |
| Monthly income | |||||
| <308 | 8.1 (7.5, 8.8) | 8.3 (7.5, 9.5) | 8.3 (7.4, 9.7) | 0 (ref) | 0 (ref) |
| 308–769 | 8.1 (7.6, 9.2) | 7.9 (6.9, 9.0) | 7.8 (7.0, 9.0) | −0.32 (0.14) * | −0.40 (0.13) ** |
| ≥769 | 8.0 (7.5, 9.2) | 8.0 (7.2, 9.1) | 7.7 (6.9, 8.8) | −0.31 (0.16) * | −0.34 (0.15) * |
| Tobacco use (%) | |||||
| Never | 8.1 (7.6, 9.1) | 8.0 (7.1, 9.1) | 7.9 (7.0, 9.0) | 0 (ref) | 0 (ref) |
| Ever | 8.0 (7.5, 9.2) | 8.2 (7.1, 9.3) | 8.2 (7.1, 9.4) | 0.09 (0.14) | -0.01 (0.14) |
| Alcohol drinking (%) | |||||
| Never | 8.1 (7.6, 9.1) | 8.0 (7.0, 9.1) | 7.9 (6.9, 9.1) | 0 (ref) | 0 (ref) |
| Ever | 8.3 (7.5, 9.2) | 8.3 (7.2, 9.3) | 8.3 (7.4, 9.2) | 0.08 (0.15) | -0.01 (0.15) |
| Years of diabetes | |||||
| <10 | 8.0 (7.5, 8.9) | 7.7 (6.9, 9.0) | 7.7 (6.8, 8.9) | 0 (ref) | 0 (ref) |
| ≥10 | 8.2 (7.7, 9.4) | 8.1 (7.4, 9.3) | 8.0 (7.2, 9.2) | 0.37 (0.09) ** | 0.31 (0.09) ** |
| Medications (%) | |||||
| Diabetes pills only | 8.1 (7.5, 9.1) | 7.9 (7.0, 9.1) | 7.9 (6.9, 9.1) | 0.09 (0.18) | 0.02 (0.17) |
| Insulin shot only | 8.1 (7.6, 9.5) | 8.4 (7.3, 9.0) | 8.0 (7.3, 9.2) | 0.10 (0.12) | 0.06 (0.11) |
| Neither | 8.0 (7.5, 8.9) | 7.7 (6.8, 9.5) | 7.3 (6.7, 8.2) | 0 (ref) | 0 (ref) |
| Both | 8.3 (7.8, 9.2) | 8.3 (7.4, 9.4) | 8.0 (7.1, 9.4) | −0.19 (0.21) | −0.10 (0.20) |
| c-HeLMS score | |||||
| <116 | 8.1 (7.6, 9.2) | 8.0 (7.1, 9.1) | 7.9 (6.8, 9.1) | 0 (ref) | 0 (ref) |
| ≥116 | 8.1 (7.6, 9.1) | 7.9 (7.0, 9.1) | 7.8 (7.1, 9.0) | 0.04 (0.10) | 0.04 (0.09) |
| Correct rate of c-DNT-5 | |||||
| <80 | 8.3 (7.7, 9.4) | 8.0 (7.1, 9.1) | 7.7 (6.8, 9.2) | 0 (ref) | 0 (ref) |
| ≥80 | 8.1 (7.5, 9.0) | 8.0 (7.1, 9.1) | 7.9 (7.0, 9.0) | −0.01 (0.11) | 0.11 (0.10) |
| PA level (Mets, by tertile) | |||||
| <42 | 8.2 (7.7, 9.0) | 8.0 (7.1, 9.0) | 8.0 (6.9, 9.1) | 0 (ref) | 0 (ref) |
| 42–78 | 8.1 (7.5, 9.2) | 7.9 (7.0, 9.2) | 7.8 (7.0, 9.0) | 0.04 (0.12) | 0.07 (0.11) |
| ≥78 | 8.1 (7.5, 9.2) | 8.1 (7.1, 9.3) | 7.9 (7.0, 9.0) | −0.05 (0.12) | −0.02 (0.12) |
SE: Standard Error; USD: USA dollar; HeLMS: Health Literacy Management Scale; c-DNT-5: the 5-item Diabetes Numeracy Test scale; β derived from three-level mixed regression models (intervention status are level-3 observation units, individuals are level-2 and repeated measurements are level-1). a adjusted for age, sex, and baseline HbA1c; * p value < 0.05; ** p value < 0.01.
Baseline characteristics of the study participants by tertile groups of PA at the follow-up surveys.
| Characteristics at Baseline | PA Level at the 12-Month Survey (METs-h/w) | PA Level at the 24-Month Survey (METs-h/w) | ||||||
|---|---|---|---|---|---|---|---|---|
| Tertile Group 1 | Tertile Group 2 | Tertile Group 3 | Tertile Group 1 | Tertile Group 2 | Tertile Group 3 | |||
| Age (years, median, IQR) a | 67 (60, 74) | 67 (60, 72) | 64 (58, 69) | <0.001 | 68 (60, 74) | 66 (59, 70) | 64 (59, 70) | 0.002 |
| Sex of men (%) b | 53.8 | 46.8 | 37.0 | <0.001 | 53.7 | 36.5 | 44.1 | 0.045 |
| Educational level (%) b | 0.118 | 0.432 | ||||||
| Primary school or below | 25.1 | 26.6 | 15.7 | 27.2 | 18.7 | 20.9 | ||
| Junior high school | 35.3 | 39.1 | 40.9 | 34.5 | 39.7 | 40.0 | ||
| Senior high school | 26.4 | 19.3 | 29.4 | 24.9 | 25.2 | 25.5 | ||
| College and above | 12.2 | 15.0 | 14.0 | 13.4 | 16.4 | 13.6 | ||
| Monthly income per capita (USD, %) b | 0.482 | 0.838 | ||||||
| <308 | 13.5 | 18.7 | 11.5 | 20.0 | 11.7 | 12.9 | ||
| 308–769 | 53.0 | 59.6 | 61.3 | 49.8 | 58.7 | 62.7 | ||
| >769 | 33.5 | 21.7 | 27.2 | 30.2 | 29.6 | 24.4 | ||
| Tobacco smoking (%) b | 18.8 | 13.4 | 14.6 | 0.210 | 15.3 | 14.6 | 14.3 | 0.771 |
| Alcohol drinking (%) b | 14.2 | 11.9 | 8.3 | 0.045 | 16.6 | 10.1 | 7.6 | 0.003 |
| Years of diabetes (median, IQR) a | 10.0 (5.3, 16.4) | 9.8 (5.0, 14.8) | 9.4 (4.8, 15.1) | 0.362 | 11.0 (5.5, 17.0) | 8.9 (4.8, 14.9) | 9.7 (5.0, 15.0) | 0.026 |
| Use of anti-diabetes agents and insulin (%) b | 0.024 | 0.660 | ||||||
| Diabetes pills only | 61.9 | 67.2 | 52.1 | 62.2 | 64.4 | 61.5 | ||
| Insulin shot only | 10.2 | 4.9 | 9.3 | 10.1 | 7.3 | 8.9 | ||
| Both | 24.8 | 23.0 | 49.4 | 22.0 | 23.4 | 22.1 | ||
| Neither | 3.1 | 4.9 | 9.2 | 5.7 | 4.9 | 7.5 | ||
| PA level (MET/h-w, median, IQR) a | 49.0 (26.6, 73.0) | 56.0 (33.0, 84.0) | 77.0 (48.7, 112.0) | <0.0001 | 50.5 (24.0, 80.7) | 63.0 (41.0, 90.0) | 69.3 (44.4, 104.0) | <0.0001 |
| HbA1c level (%) b | 8.2 (7.6, 9.2) | 8.1 (7.5, 9.0) | 8.2 (7.5, 9.3) | 0.655 | 8.2 (7.6, 9.2) | 8.2 (7.5, 9.2) | 8.1 (7.6, 8.9) | 0.567 |
| HbA1c < 7.0% (%) b | 22.5 | 22.3 | 21.7 | 0.844 | 26.2 | 24.3 | 25.9 | 0.956 |
| Energy Intake (Kcal, median, IQR) a | 1448 (1116, 1793) | 1522 (1197, 1826) | 1380 (1130, 1691) | 0.120 | 1467 (1134, 1821) | 1433 (1132, 1720) | 1410 (1141, 1711) | 0.384 |
a Continuous variables were presented as medians and interquartile range (IQR); b Categorical variables were presented as frequency and percentages. p-values for one-way ANOVA or Kruskal–Wallis tests (continuous variables) and chi-square tests (categorical variables).
Associations of PA level with improvements in HbA1c among the study participants.
| Associations of PA level with HbA1c | Tertile Groups by PA Level (METs-h/w) a | Achievement of Recommended Exercise Level | |||||
|---|---|---|---|---|---|---|---|
| Lowest | Medium | Highest | No | Yes | |||
| At 12 months | |||||||
| Number of subjects | 236 | 233 | 235 | 391 | 313 | ||
| HbA1c (%, median, IQR) | 8.0 (7.1, 9.0) | 7.9 (7.0, 9.2) | 8.1 (7.1, 9.3) | 0.561 | 8.0 (7.1, 9.2) | 7.9 (7.0, 9.0) | 0.276 |
| HbA1c < 7.0% ( | 53 (22.5) | 52 (22.3) | 51 (21.7) | 0.844 | 87 (22.3) | 69 (22.0) | 0.948 |
| β1 (95%CI) | 0 (ref) | 0.12 (−0.16, 0.40) | 0.15 (−0.15, 0.45) | 0 (ref) | −0.15 (−0.39, 0.09) | ||
| β2 (95%CI) | 0 (ref) | 0.15 (−0.12, 0.42) | 0.06 (−0.23, 0.35) | 0 (ref) | −0.05 (−0.29, 0.18) | ||
| β3 (95%CI) a | 0 (ref) | −3.47 (−5.33, −1.60) | −0.85 (−2.58, 0.88) | 0 (ref) | −0.28 (−0.54, −0.02) | ||
| At 24 months | |||||||
| Number of subjects | 218 | 214 | 220 | 372 | 280 | ||
| HbA1c (%, median, IQR) | 8.0 (6.9, 9.1) | 7.9 (7.0, 8.9) | 7.8 (6.9, 9.0) | 0.794 | 7.8 (6.3, 9.0) | 7.9 (6.9, 9.1) | 0.816 |
| HbA1c < 7.0% ( | 57 (26.2) | 52 (24.3) | 57 (25.9) | 0.956 | 94 (25.3) | 72 (25.7) | 0.897 |
| β1 (95%CI) | 0 (ref) | −0.01 (−0.31, 0.29) | −0.17 (−0.47, 0.14) | 0 (ref) | −0.07 (−0.33, 0.18) | ||
| β2 (95%CI) | 0 (ref) | 0.03 (−0.25, 0.31) | −0.10 (−0.39, 0.19) | 0 (ref) | −0.01 (−0.25, 0.23) | ||
| β3 (95%CI) | 0 (ref) | −0.04 (−0.49, 0.41) | −0.50 (−1.00, −0.01) | 0 (ref) | −1.65 (−3.12, −0.18) | ||
| From baseline to 24 months | |||||||
| β (95%CI) | 0 (ref) | −1.29 (−3.33, 0.75) | −3.49 (−5.87, −1.11) | 0 (ref) | −0.20 (−0.38, −0.02) | ||
a Cut-off points for tertile groups of PA were 38.7 and 77.0 Mets/h-w at 12-months, and 38.8 and 82.0 Mets/h-w at 24-months, respectively; β1, β2, and β3 derived from two-level mixed regression models with individuals as the level-2 and intervention status as the level-1 observations; β1 adjusted for age and sex; β2 additionally adjusted for use of anti-diabetes agents and insulin, duration of diabetes, and baseline levels of HbA1c and PA; β3 additionally adjusted for use of anti-diabetes agents and insulin, duration of diabetes, initial levels of HbA1c and PA, and interactions of PA with initial level of PA and HbA1c. β derived from three-level mixed regression models with individuals as the level-3, intervention status as the level-2 and repeated measurements of PA as the level-1 observations, and adjusted for age, sex, income, use of anti-diabetes agents and insulin, duration of diabetes, baseline levels of A1c and PA, and interactions of PA with baseline levels of PA and HbA1c. Reclassifying the subjects into two groups according to their leisure time activities using the WHO recommended exercise level (10 MET-hours/week) as the cut-off point observed similar results. After adjusting for potential confounders including interactive variables, a significant improvement in HbA1c level was observed for patients achieving goal exercise level versus those not from baseline to 12 months (β: −0.31, 95%CI: −0.56, −0.05), from 12 to 24 months (β:−1.65, 95%CI: −3.12, −0.18) and from baseline to 24 months (β:−0.20, 95%CI: −0.38, −0.02).
Figure 2Associations of HbA1c with levels of specific type of PA (Physical Activity). a Two-level mixed regression models with individuals as the level-2 and intervention status as the level-1 observations, and adjusted for age, sex, anti-diabetes drug use or insulin use, duration of diabetes, initial levels of A1c and PA, overall PA level; b Three-level mixed regression models with individuals as the level-3, intervention status as the level-2, and repeated measurements of PA as the level-1 observations, and adjusted for age, sex, anti-diabetes drug or insulin use, duration of diabetes, baseline levels of A1c and PA, and overall PA level.
Figure 3β coefficients and 95% confidence intervals for PA with HbA1c at 12 and 24 months by initial levels of PA and HbA1c. a Two-level mixed regression models with individuals as the level-2 observations and intervention status as shown in Table 1 and adjusted for age, sex, use of anti-diabetes agents and insulin, duration of diabetes, and initial PA level (for stratified analysis by initial HbA1c only) or initial HbA1c level (for stratified analysis by initial PA only); b Three-level mixed regression models with individuals as the level-3, intervention status as the level-2 and repeated measurements of PA as the level-1 observations, and adjusted for age, sex, use of anti-diabetes agents and insulin, duration of diabetes, and initial PA level (for stratified analysis by initial HbA1c only) or initial HbA1c level (for stratified analysis by initial PA only).